Synergism between poly-(1-6)-β-D-glucopyranosyl-(1-3)-β-D- glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model

Abstract

To determine whether the infection-preventing capability of the neutrophil-activating agent poly-(1-6)-β-D-glucopyranosyl-(1-3)-β-D- glucopyranose glucan (PGG-glucan) can be enhanced with antibiotic prophylaxis, we administered PGG-glucan and cefazolin, alone and in combination, to guinea pigs inoculated with isolates of staphylococci. Guinea pigs receiving both PGG-glucan and cefazolin had 50% infective doses that were 8- to 20-fold higher than those obtained with cefazolin alone and 100- to 200-fold higher than those obtained with PGG-glucan alone. PGG-glucan and cefazolin are synergistic in their ability to prevent staphylococcal wound infection.